logo
BITS Pilani, Hyderabad develops plant-based cure for Thalassaemia, Sickle Cell Anaemia

BITS Pilani, Hyderabad develops plant-based cure for Thalassaemia, Sickle Cell Anaemia

Time of India14-05-2025
Hyderabad: Researchers at the
BITS Pilani
, Hyderabad, have developed a
plant-based drug formulation
that could offer more affordable treatment for iron overload, a condition common in patients with Thalassaemia and
Sickle Cell Anaemia
. The new formulation, tested successfully on rats and mice, uses compounds found in plants to remove excess iron from the body and does so using a much lower dosage than the standard treatment available in the market today.
Published in the journal Molecular Pharmaceutics, the study explains how the team combined caffeic acid, a naturally occurring compound, with amino acids to create two formulations: Caffeic Acid–Spermine (CA-Sp) and Caffeic Acid–Histidine (CA-His). "When compared with the current drug in use, CA-Sp required just one-fifth of the dosage to remove excess iron," said department of biological sciences professor Jayati Ray Dutta. She worked on the project along with Ramakrishnan Ganesan from the department of chemistry. Researchers pointed out that even though the treatment duration was kept the same for comparison, the new drug showed better iron removal and lower toxicity. "We tested for liver inflammation and found that our drug performed better than the standard one," Dutta said. Apart from effectiveness, the formulation also scores high on affordability. "The current drug costs about 300 per dose. Our plant-based formulation could cut the cost by more than 50%," she added. The researchers used the natural iron-binding ability of polyphenols and paired them with compounds known as biogenic amines, which are commonly found in nature. "This is a step forward in developing green, affordable therapies for transfusion-dependent patients. It has the potential to transform iron overload treatment, not just in India but globally," said Ganesan. Iron overload is a growing concern in India, especially among patients with Thalassaemia and Sickle Cell Anaemia who depend on frequent blood transfusions. Left untreated, excess iron can severely damage the liver, heart, and endocrine system, they added and pointed out that India is home to over 100,000 Thalassaemia patients, many of whom require perpetual
iron chelation therapy
(ICT) to manage iron toxicity.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Monica Seles opens up about life-changing chronic neuromuscular disease - here are details of condition
Monica Seles opens up about life-changing chronic neuromuscular disease - here are details of condition

Time of India

timean hour ago

  • Time of India

Monica Seles opens up about life-changing chronic neuromuscular disease - here are details of condition

Monica Seles myasthenia gravis : Monica Seles, the tennis legend and nine-time Grand Slam winner, has shared for the first time that she was diagnosed with myasthenia gravis, a neuromuscular autoimmune disease that causes muscle weakness, three years ago, as per a report. Monica Seles Reveals How She First Noticed Symptoms Of Myasthenia Gravis The International Tennis Hall of Famer said that she first noticed the symptoms while she was swinging a racket the way she had done multiple times during and after a career, as reported by ESPN. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program She revealed that, "I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore," as quoted in the report. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Undo Seles, who played her last match in 2003, highlighted that she had never heard of the condition until consulting a doctor and being referred to a neurologist after noticing symptoms like double vision and weakness in her arms and legs, saying, "just blowing my hair out ... became very difficult," as quoted by the ESPN report. ALSO READ: Apple in hot water as Elon Musk accuses Tim Cook-led company for favoring AI rivals like ChatGPT, to file suit Live Events Speaking Out to Raise Awareness The 51-year-old Seles pointed out that, "And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot," as quoted by ESPN. She has decided to publicly speak about her diagnosis, with the aim of raising awareness about what is known as "MG", as per the report. Seles described what it felt like after she was diagnosed with MG, saying, "When I got diagnosed, I was like, 'What?!'" adding, "So this is where -- I can't emphasize enough -- I wish I had somebody like me speak up about it," as quoted in the report. ALSO READ: Do Nvidia's H20 chips pose security risks? China sounds alarm, orders firms to avoid them Understanding Myasthenia Gravis: What Is MG? The National Institute of Neurological Disorders and Stroke described that it is "a chronic neuromuscular disease that causes weakness in the voluntary muscles" and "most commonly impacts young adult women (under 40) and older men (over 60) but ... can occur at any age, including childhood," according to the ESPN report. Monica Seles Adjusting to a 'New Normal' with MG Seles, who won her first major trophy at age 16 at the 1990 French Open, has learned to live a "new normal" now, and emphasised that her health is another in a series of life steps that required adapting, as reported by ESPN. She explained that, "I had to, in tennis terms, I guess, reset -- hard reset -- a few times," adding, "I call my first hard reset when I came to the U.S. as a young 13-year-old [from Yugoslavia]. Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes [everything], and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing -- I had to do a huge reset," as quoted in the report. Seles highlighted that, "And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust.' And that's what I'm doing now," as quoted in the ESPN report. FAQs What is myasthenia gravis ? MG is an autoimmune disease that weakens voluntary muscles, making movement and daily tasks difficult, as per the ESPN report. How did Monica Seles realize something was wrong? She noticed symptoms like double vision and missing tennis balls during casual play.

Apollo Hospitals Q1 Results: Cons PAT surges 42% YoY to Rs 433 crore, revenue rises 15%
Apollo Hospitals Q1 Results: Cons PAT surges 42% YoY to Rs 433 crore, revenue rises 15%

Time of India

timean hour ago

  • Time of India

Apollo Hospitals Q1 Results: Cons PAT surges 42% YoY to Rs 433 crore, revenue rises 15%

Apollo Hospitals Enterprise on Tuesday reported a consolidated net profit of Rs 433 crore in Q1, up 42% compared to Rs 305 crore reported in the year ago period. The profit after tax (PAT) was attributable to the owners of the company. Company's revenue from operations in the quarter grew 15% to Rs 5,842 crore versus Rs 5,086 crore in Q1FY25. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program The PAT was 11% higher on a sequential basis versus Rs 390 crore in Q4FY25 while the topline increased 4.5% over Rs 5,592 reported by the company in Q4FY25. The earnings were announced after market hours and Apollo Hospitals shares ended with minor downtick at Rs 7,253 on the NSE. Segment revenue The company earned its revenues from healthcare services, Retail health & diagnostics, Digital health & pharmacy distribution and also as other income. -- Healthcare services revenue stood at Rs 2,974 crore in Q1FY26 versus Rs 2,843 crore in Q4FY25 and Rs 2,654 crore in Q1FY25. -- Retail health & diagnostics revenue stood at Rs 435 crore in Q1FY26 versus Rs 394 crore in Q4FY25 and Rs 366 crore in Q1FY25. -- Digital health & pharmacy distribution revenue stood at Rs 2,472 crore in Q1FY26 versus Rs 2,376 crore in Q4FY25 and Rs 2,082 crore in Q1FY25. Also Read: Nykaa Q1 Results: Cons PAT soars 79% YoY to Rs 24 crore, revenue jumps 23% Q1 Expenses The company's expenses were reported at Rs 5,313 crore, up on a YoY and QoQ basis. In the previous quarter, Apollo Hospitals had reported expenses of Rs 5,148 crore while Rs 4,704 crore in the year ago period. The expenses were made on material used by the hospital, purchases of stock-in-trade, employee benefits and as finance cost. Acquisition The company's Board of Directors today approved an investment of Rs 8.5 crore for acquiring 85 lakh equity shares of Apollo Gleneagles PET-CT Private Limited (AGPCL) from its existing shareholder, Parkway Healthcare (Mauritius) PTE Limited, representing capital of AGPCL. Also Read: NSDL Q1 Results: Cons PAT jumps 15% YoY to Rs 90 crore despite 7% drop in revenue

Monica Seles speaks about myasthenia gravis diagnosis, says ‘that ball is bouncing, you've just got to adjust'
Monica Seles speaks about myasthenia gravis diagnosis, says ‘that ball is bouncing, you've just got to adjust'

Time of India

time2 hours ago

  • Time of India

Monica Seles speaks about myasthenia gravis diagnosis, says ‘that ball is bouncing, you've just got to adjust'

Monica Seles , winner of nine Grand Slam titles and a member of the International Tennis Hall of Fame , has spoken publicly for the first time about being diagnosed with myasthenia gravis . She received the diagnosis three years ago and chose to share her experience now to raise awareness before the US Open begins on 24 August. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles told The Associated Press. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.' Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program What is myasthenia gravis? The National Institute of Neurological Disorders and Stroke describes myasthenia gravis as 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and notes it 'most commonly impacts young adult women (under 40) and older men (over 60) but can occur at any age, including childhood.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Undo Seles said she had never heard of the illness before her diagnosis. The first signs appeared when she began experiencing double vision and weakness in her arms and legs. 'Just blowing my hair out ... became very difficult,' she said. 'When I got diagnosed, I was like, 'What?!'' Seles said. 'So this is where I can't emphasise enough, I wish I had somebody like me speak up about it.' Live Events She has since partnered with argenx, an immunology company based in the Netherlands, to promote their Go for Greater campaign aimed at increasing awareness of the disease. Who is Monica Seles: A career defined by resilience Seles's career was marked by early success, with her first major win at the 1990 French Open aged just 16. She last played professionally in 2003. Her resilience was tested long before her diagnosis. In 1993, she was stabbed by a man during a match in Hamburg, Germany, and was away from the sport for more than two years. She returned at the 1995 US Open, reaching the final. 'The way they welcomed me ... after my stabbing, I will never forget,' she said of the New York crowd. 'Those are the moments that stay with you.' Seles describes her diagnosis as another moment in life that required a complete readjustment. 'I had to, in tennis terms, I guess, reset — hard reset — a few times,' she said. 'I call my first hard reset when I came to the U.S. as a young 13-year-old [from Yugoslavia]. Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes [everything], and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing — I had to do a huge reset. 'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust.' And that's what I'm doing now.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store